Celgene (CELG) Profit Margin History

Historical gross, operating and net quarterly profit margin for Celgene (CELG) over the last 10 years. The current net profit margin for Celgene as of November 17, 2017 is 27.36%.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $81.960B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.